Interpretative reading of the antibiogram. Luis Martínez-Martínez Service of Microbiology University Hospital Marqués de Valdecilla Santander, Spain

Similar documents
ESCMID Online Lecture Library. by author

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

BSAC antimicrobial susceptibility

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING

EUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM)

EUCAST Expert Rules for Staphylococcus spp IF resistant to isoxazolylpenicillins

Principles and Practice of Antimicrobial Susceptibility Testing. Microbiology Technical Workshop 25 th September 2013

Towards Rational International Antibiotic Breakpoints: Actions from the European Committee on Antimicrobial Susceptibility Testing (EUCAST)

Antimicrobial Resistance Strains

Journal of Antimicrobial Chemotherapy Advance Access published October 3, 2011

INTERPRETATIVE READING. Tan Thean Yen

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance

PROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains

Received 10 November 2006/Returned for modification 9 January 2007/Accepted 17 July 2007

Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria

ESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL

Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory

CONTAGIOUS COMMENTS Department of Epidemiology

Antimicrobial Stewardship Strategy: Antibiograms

Evaluation of a new cefepime clavulanate ESBL Etest to detect extended-spectrum b-lactamases in an Enterobacteriaceae strain collection

European Committee on Antimicrobial Susceptibility Testing

Antimicrobial Cycling. Donald E Low University of Toronto

ESCMID Online Lecture Library. by author

European Committee on Antimicrobial Susceptibility Testing

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

Michael Hombach*, Guido V. Bloemberg and Erik C. Böttger

The First Report of CMY, AAC(6')-Ib and 16S rrna Methylase Genes among Pseudomonas aeruginosa Isolates from Iran

Why we perform susceptibility testing

Practical approach to Antimicrobial susceptibility testing (AST) and quality control

CONTAGIOUS COMMENTS Department of Epidemiology

by author ESCMID Online Lecture Library EUCAST The European Committee on Antimicrobial Susceptibility Testing September 2010

Christiane Gaudreau* and Huguette Gilbert

Antimicrobial consumption and impact on resistance

APPENDIX III - DOUBLE DISK TEST FOR ESBL

Susceptibility Testing and Resistance Phenotypes Detection in Bacterial Pathogens Using the VITEK 2 System

Saxena Sonal*, Singh Trishla* and Dutta Renu* (Received for publication January 2012)

Infection Control of Emerging Diseases

Main objectives of the EURL EQAS s

Detection of inducible clindamycin resistance among clinical isolates of Staphylococcus aureus in a tertiary care hospital

Antibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017

STAPHYLOCOCCI: KEY AST CHALLENGES

biomérieux S.A Marcy l Etoile France Tel. : 33 (0) Fax : 33 (0)

TECHNICAL REPORT External quality assessment of laboratory performance European Antimicrobial Resistance Surveillance Network (EARS-Net), 2017

β-lactams resistance among Enterobacteriaceae in Morocco 1 st ICREID Addis Ababa March 2018

Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges

Prevalence of Ciprofloxacin Resistance Among Gram-Negative Bacilli at a Specialist Hospital in Saudi Arabia

Other β-lactamase Inhibitor (BLI) Combinations: Focus on VNRX-5133, WCK 5222 and ETX2514SUL

Witchcraft for Gram negatives

Mili Rani Saha and Sanya Tahmina Jhora. Department of Microbiology, Sir Salimullah Medical College, Mitford, Dhaka, Bangladesh

Microbiology. Multi-Drug-Resistant bacteria / MDR: laboratory diagnostics and prevention. Antimicrobial resistance / MDR:

Int.J.Curr.Microbiol.App.Sci (2018) 7(8):

Antibiotic resistance. why? mechanisms Belgian situation (as an example) With the support of Wallonie-Bruxelles-International

THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS

RETROSPECTIVE STUDY OF GRAM NEGATIVE BACILLI ISOLATES AMONG DIFFERENT CLINICAL SAMPLES FROM A DIAGNOSTIC CENTER OF KANPUR

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

Relationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae

CHINA: Progress report on the aquaculture component of country NAPs on AMR

Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC

Microbiology Basics and Applications to Clinical Practice

Beta-lactamase Inhibitors May Induce Resistance to Beta-lactam Antibiotics in Bacteria Associated with Clinical Infections Bhoj Singh

ESCMID Online Lecture Library. by author

International Journal of Antimicrobial Agents 28 (2006)

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes

Prevalence of Extended-spectrum β-lactamase Producing Enterobacteriaceae Strains in Latvia

Mechanism of antibiotic resistance

Comparison of Antibiotic Resistance and Sensitivity with Reference to Ages of Elders

International Journal of Health Sciences and Research ISSN:

2015 Antimicrobial Susceptibility Report

Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City

Study of drug resistance pattern of principal ESBL producing urinary isolates in an urban hospital setting in Eastern India

JAC Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests

Monitoring of antimicrobial resistance in Campylobacter EURL AR activities in framework of the new EU regulation Lina Cavaco

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

IMPORTANCE OF GLOBAL HARMONIZATION OF ANTIMICROBIAL SUSCEPTIBILITY TESTING IN CANADA FOR DEFINING ANTIMICROBIAL RESISTANCE

Intrinsic, implied and default resistance

Originally published as:

Pneumococci & streptococci Testing and clinical implications of susceptibility changes

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

Original Article. Ratri Hortiwakul, M.Sc.*, Pantip Chayakul, M.D.*, Natnicha Ingviya, B.Sc.**

3/9/15. Disclosures. Salmonella and Fluoroquinolones: Where are we now? Salmonella Current Taxonomy. Salmonella spp.

Rapid Diagnosis by Multiplex PCR Technology at Patients with Acute Respiratory Infections

Version 1.01 (01/10/2016)

Susceptibility testing of Salmonella and Campylobacter

Prevalence of Extended Spectrum Beta- Lactamase Producers among Various Clinical Samples in a Tertiary Care Hospital: Kurnool District, India

2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital

PILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 1996

Independent Emergence of Colistin-Resistant Enterobacteriaceae. clinical isolates without colistin treatment

Antimicrobial Resistance: A Growing Concern for Healthcare Security and Resilience

Laboratory determination of the susceptibility to antibiotics of bacteria isolated from aquatic animals Peter Smith

The impact of antimicrobial resistance on enteric infections in Vietnam Dr Stephen Baker

JAC Cross-resistance patterns among clinical isolates of Klebsiella pneumoniae with decreased susceptibility to cefuroxime

Towards Rational International Antibiotic Breakpoints: Actions from the European Committee on Antimicrobial Susceptibility Testing (EUCAST)

Multidrug-Resistant Salmonella enterica in the Democratic Republic of the Congo (DRC)

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

G. Valenza, S. Müller, C. Schmitt, D. Turnwald, T-T. Lam, M. Frosch, M. Abele-Horn, Y. Pfeifer

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

ETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae

Fighting MDR Pathogens in the ICU

Transcription:

Interpretative reading of the antibiogram Luis Martínez-Martínez Service of Microbiology University Hospital Marqués de Valdecilla Santander, Spain

ANTIBIOGRAM RESISTANCE SUSCEPTIBILITY ANTIMICROBIAL AGENT TOXICITY PK/PD MICRO- ORGANISM VIRULENCE MECHANISMS OF DEFENSE PATIENT

Description of mechanisms of resistance Introduction into clinical practice Relationship between resistance and therapeutic failure Susceptibility testing standardization Automation and expert systems Interpretative reading Interpretative criteria Discovery of antimicrobial agents 1920 1930 1940 1950 1960 1970 1980 1990 2000

Antibiogram Reading Ø Inh. zone (mm) MIC (mg/l) S-I-R

Clinical Categories CLSI (NCCLS): Clinical and Laboratory Standards Institute EUCAST: European Committee on Antimicrobial Susceptibility Testing SFM: Société Française de Microbiologie BSAC: British Society for Antimicrobial Chemotherapy MENSURA: Mesa Española de Normalización de la Sensibilidad y Resistencia a los Antimicrobianos...

Patrice Courvalin. Interpretative reading of antimicrobial susceptibility test. ASM News 1992, 58:368-375.

ANTIBIOGRAM Interpreative reading of the antibiogram Phenotype - Resistance Susceptibility testing results for a concrete microorganism considering a GROUP of antimicrobial agents (usually of the same family)

ANTIBIOGRAM Interpreative reading of the antibiogram 1.- Define Phenotype of susceptibility and Resistance 2.- Deduce the possible mechanism of resistence 3.- Adequate Clinical Categories to the inferred mechanism of resistance, and change phenotype if necessary

ANTIBIOGRAM Interpreative reading of the antibiogram S-I-R Microbiological Knowldge CLINCAL REPORT OF RESULTS

AES S-I-R SOFTWARE (Expert system) CLINCAL REPORT OF RESULTS

INTERPRETATION

[Not available in English!]

[Not available in English!]

Interpreative reading Identification of the microorganism (To species level)) Analysis of susceptibility/resistance Phenotype - Groups (families) of antimicrobial agents - Antimicrobial indicators of resistance Define Phenotype - Common Phenotypes - Unusual Phenotypes - Impossible Phenotypes Deduce biochemical mechanism of resistance Clinical Relevance of the inferred resistance Re-define Clinical Categories

Requirements of Interpretative reading of the antibiogram Identification of the microorganism Analysis of S/I/R phenotype Use of indicator agents Study antibiotic-inhibitor combinations Quantitative study of susceptibility Use of high inocula (in some occasions) Local epidemiology information Availability of reference methods R. Cantón. Enferm Infecc Microbiol Clin 2002; 20: 176-186

Microorganism Identification + antibiogram Antibiogram Interpretation Clinical Relevance of the mechanism of resistance Deduce Phenotype of Resistance Deduce Biochemical Mechanism of Resistance Re-Define Clinical Categories, if necessary REPORT Deduce susceptibility/resistance to non tested antimicrobial agents

Livermore D et al JAC 12001, 48 Suppl 1, 87-102

Livermore D et al JAC 12001, 48 Suppl 1, 87-102

Livermore D et al JAC 12001, 48 Suppl 1, 87-102

Livermore D et al JAC 12001, 48 Suppl 1, 87-102

Livermore D et al JAC 12001, 48 Suppl 1, 87-102

Livermore D et al JAC 12001, 48 Suppl 1, 87-102

Livermore D et al JAC 12001, 48 Suppl 1, 87-102

K. pneumoniae K. pneumoniae ESBL (+)

CPM CPM CTX IMP CAZ CTX IMP CAZ AMP AMP Enterobacter cloacae

SHV-12 IN Enterobacter

Klebsiella pneumoniae CMY-2 Mueller- Hinton Cloxacillin 250 mg/l Mueller-Hinton

MβL

Staphylococcus aureus P E E OX erm AK Macrolides-14 R -15 R -16? PBP2a CN APH(2 )-AAC(6 ) ß-lactam R Aminoglicosyde R

S. aureus E DA DA E DA E erm Inducible methylase erm constitutive methylase msra-b Active efflux

qnrs-producing Enterobacter cloacae REP-PCR REP-PCR pattern A B C D E Isolates number 14 4 2 1 1 MIC nalidixic acid (mg/l) >256 (R) 8 (S) 8-16 (S) >256 (R) 32 (R) MIC ciprofloxacin (mg/l) >32 (R) 0.38 (S) 2-4 (I/R) 3 (R) 1.5 (I) Mutations in gyra Ser83Ile (14) Asp87Asn (1) None None Ser83Phe None Mutations in parc Ser80Ile (2) Not done (12) Not done None Not done None Cano ME et al, submitted

Enterobacteriaceae COLISTIN RESISTANCE Calvo J et al unpublished results

Limitations to interpretative reading of the antibiogram High complexity of resistance mechanisms Limited information about some mechanisms of resistance Low level resistance Multifactorial multiresistance Oversimplification of interrpetative reading Mistakes when deducing mechanisms of resistance Modified from: R. Cantón. Enferm Infecc Microbiol Clin 2002; 20:176-186

Benefits of the interpretative reading of the antibiogram Adequacy of antimicrobial therapy Detection of new mechanisms of resistence Analysis of epidmeiology of resistance Antimicrobial policy Improved quality in laboratory testing Modified from: R. Cantón. Enferm Infecc Microbiol Clin 2002; 20:176-186